What is the appropriate dose of 2% Lugol's iodine oral solution for pre‑treatment of a hyperthyroid patient undergoing thyroidectomy to prevent thyroid storm?

Dosing of Lugol's Iodine 2% Solution for Preoperative Thyroid Surgery

For hyperthyroid patients preparing for thyroidectomy, administer 5-7 drops (0.25-0.35 mL) of Lugol's solution three times daily, mixed in water or juice, for 10 days before surgery. 11111

Rationale and Evidence Base

The American Thyroid Association and American Association of Clinical Endocrinologists guidelines explicitly specify this dosing regimen in their technical remarks. Each drop of Lugol's solution contains approximately 8 mg of iodide, making the total daily dose approximately 120-168 mg of iodide when given three times daily 111.

Clinical Context and Timing

Primary Approach

• First-line strategy: Render the patient euthyroid with methimazole before surgery whenever possible 111
• Add Lugol's solution: Administer in the immediate preoperative period (the 10 days before surgery) even if the patient is already euthyroid on antithyroid drugs 11

Exceptional Circumstances

When methimazole cannot be used (allergy, insufficient time, urgent surgery need), combine:

• Beta-adrenergic blockade
• Lugol's solution at the same dose (5-7 drops three times daily for 10 days)
• Experienced surgeon and anesthesiologist 11

Mechanism and Benefits

Lugol's solution works by:

• Reducing thyroid blood flow: Decreases vascularity and intraoperative blood loss 112
• Decreasing gland friability: Makes surgical dissection safer
• Preventing thyroid storm: The stress of surgery, anesthesia, and thyroid manipulation can precipitate thyroid storm; pretreatment helps prevent this life-threatening complication 111

Research demonstrates that Doppler ultrasound shows significant reduction in intrathyroid arterial flow after Lugol's treatment, with normalization of the low-resistance vascular pattern seen in hyperthyroidism 32.

Important Caveats and Pitfalls

Critical Timing Issue

• Do NOT use Lugol's solution for toxic multinodular goiter (TMNG) or toxic adenoma (TA) preparing for surgery 1. The guidelines explicitly state that preoperative iodine should not be used in this setting, as iodine can worsen hyperthyroidism in autonomous nodular disease.
• This recommendation applies specifically to Graves' disease patients

Emerging Controversy

Recent 2026 studies challenge the necessity of routine Lugol's pretreatment:

• A large European multicenter study found that patients who did NOT receive Lugol's solution had fewer complications (lower rates of RLN injury and hypoparathyroidism) when operated on by high-volume surgeons 4
• Another 2026 study showed no significant differences in surgical outcomes between premedicated and non-premedicated patients 5

However, these studies involved high-volume thyroid surgeons. The established guideline recommendations remain the standard of care, particularly for:

• Surgeons with lower thyroid surgery volumes
• Patients with very high thyroid blood flow on preoperative assessment
• Settings where surgical expertise may be variable

Rare but Serious Risk

Drug-induced liver injury from potassium iodide has been reported, though rare 6. Monitor liver function if unexplained hepatotoxicity develops during treatment.

Practical Administration

• Preparation: Mix drops in water or juice to improve palatability
• Frequency: Three times daily (morning, afternoon, evening)
• Duration: Exactly 10 days before scheduled surgery
• Continuation: Continue antithyroid drugs throughout the Lugol's treatment period 12

Post-Operative Management

• Stop antithyroid drugs at the time of thyroidectomy 11
• Wean beta-blockers following surgery 11
• The Lugol's solution is discontinued after surgery as its purpose (reducing vascularity and preventing storm) is complete